1. Home
  2. SOPH vs XOMA Comparison

SOPH vs XOMA Comparison

Compare SOPH & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$5.05

Market Cap

367.7M

Sector

Health Care

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$32.85

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
XOMA
Founded
2011
1981
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
367.7M
308.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SOPH
XOMA
Price
$5.05
$32.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$7.00
$60.60
AVG Volume (30 Days)
94.1K
106.0K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.09
$24.95
Revenue Next Year
$19.57
$6.20
P/E Ratio
N/A
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$2.58
$18.40
52 Week High
$5.70
$39.92

Technical Indicators

Market Signals
Indicator
SOPH
XOMA
Relative Strength Index (RSI) 56.68 74.86
Support Level $4.54 $32.73
Resistance Level $5.31 $35.17
Average True Range (ATR) 0.29 1.64
MACD 0.03 0.43
Stochastic Oscillator 56.26 86.15

Price Performance

Historical Comparison
SOPH
XOMA

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: